Somnigroup International Inc. SGI
65.36 USD -1.06 (-1.59%)
At closeNov 3, 2026, 4:00 PM EST
65.35 -0.01 -0.02%
After hours · Nov 3, 4:00 PM ET
64.96 Day range 67.00
60.08 52-week range 98.56
- YTD
- -26.79%
- 1 year
- -17.76%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 92.33 +41.3% upside
Now 65.36
- Target (low)
- 80.00
- Target (mean)
- 92.33
- Target (high)
- 105.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy2
- Buy8
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 10
- 3 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.05 | 1.00 – 1.07 | 0.95 | +10.7% | 2.43B | +14.3% | 11 |
| Next quarter | 0.87859 | 0.84 – 0.93 | 0.72 | +22.0% | 2.79B | +49.1% | 11 |
| Current year | 3.11 | 3.06 – 3.16 | 2.70 | +15.2% | 8.84B | +18.2% | 11 |
| Next year | 3.85 | 3.60 – 4.08 | 3.11 | +23.8% | 11.52B | +30.3% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 14, 2026 | Stephens & Co. | Upgrade | Equal-Weight | Overweight |
| Sep 3, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Sep 3, 2026 | UBS | Maintained | Buy | Buy |
| Aug 7, 2026 | UBS | Maintained | Buy | Buy |
| Aug 7, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Aug 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 27, 2026 | Morgan Stanley | Initiated | — | Overweight |
| Jun 23, 2026 | Zelman & Assoc | Initiated | — | Outperform |
| May 8, 2026 | UBS | Maintained | Buy | Buy |
| Apr 30, 2026 | UBS | Maintained | Buy | Buy |
| Apr 14, 2026 | Stephens & Co. | Reiterated | Equal-Weight | Equal-Weight |
| Apr 14, 2026 | B of A Securities | Maintained | Buy | Buy |
| Mar 26, 2026 | Jefferies | Upgrade | Hold | Buy |
| Mar 5, 2026 | Truist Securities | Maintained | Buy | Buy |
| Feb 18, 2026 | UBS | Maintained | Buy | Buy |
| Nov 7, 2025 | UBS | Maintained | Buy | Buy |
| Nov 7, 2025 | Truist Securities | Maintained | Buy | Buy |
| Oct 13, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Sep 19, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Sep 15, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 11, 2025 | Truist Securities | Maintained | Buy | Buy |
| Aug 8, 2025 | UBS | Maintained | Buy | Buy |
| Aug 8, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 24, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Jul 2, 2025 | UBS | Maintained | Buy | Buy |
| May 9, 2025 | UBS | Maintained | Buy | Buy |
| May 9, 2025 | Piper Sandler | Reiterated | Overweight | Overweight |
| Apr 11, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Mar 13, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Mar 11, 2025 | Raymond James | Maintained | Strong Buy | Strong Buy |